Prostatype Genomics AB (OSTO:PROGEN) Accumulated Depreciation : kr0.00 Mil (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Prostatype Genomics AB's quarterly accumulated depreciation declined from Dec. 2022 (kr-0.73 Mil) to Mar. 2023 (kr0.00 Mil) but then stayed the same from Mar. 2023 (kr0.00 Mil) to Jun. 2023 (kr0.00 Mil).

Prostatype Genomics AB's annual accumulated depreciation increased from Dec. 2021 (kr-0.72 Mil) to Dec. 2022 (kr-0.73 Mil) and increased from Dec. 2022 (kr-0.73 Mil) to Dec. 2023 (kr-0.75 Mil).

Prostatype Genomics AB Accumulated Depreciation Historical Data

The historical data trend for Prostatype Genomics AB's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Accumulated Depreciation Chart

Prostatype Genomics AB Annual Data

Trend

Jun18

Jun19

Dec21

Dec22

Dec23

Accumulated Depreciation

-0.67

-0.72

-0.73

-0.75

Prostatype Genomics AB Quarterly Data
	Jun18	Jun19	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Accumulated Depreciation	Get a 7-Day Free Trial											-	-0.73	-	-	-0.75

Prostatype Genomics AB Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Prostatype Genomics AB Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB (OSTO:PROGEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

PGO:Germany

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB (OSTO:PROGEN) Headlines

No Headlines